Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kristin Stephens currently holds 25,237 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristin Stephens has been a net neutral trader of SYRS stock. They have purchased $0 and sold $0 worth of shares.
Kristin Stephens's most recent insider trade was on Oct 31, 2024, when they sold 17,000 shares at $0.00 per share.
Kristin Stephens serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 11 insider transactions totaling $0 over their tenure at the company.
Kristin Stephens holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Kristin Stephens has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Kristin Stephens was on Apr 1, 2024, when they sold $21.6K worth of SYRS shares. This transaction involved 4,218 shares at $5.12 per share.
Kristin Stephens currently owns 25,237 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kristin Stephens's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kristin Stephens has 11 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Kristin Stephens and 40,000+ other insiders.